Skip to main content
OpenTrials

Clinical trial condition

Genital Neoplasms, Female

Explore clinical trials studying Genital Neoplasms, Female. Study availability and eligibility vary by location and protocol.

4,584 public trials 1,037 recruiting studies
Refine in advanced search Browse all conditions

Genital Neoplasms, Female trial results

Recruiting

Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

NCT04291612

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +22 more
Locations
  • Hartford Healthcare Cancer Institute @ Hartford Hospital Hartford, Connecticut, United States
  • Miami Cancer Institute Baptist Health South Florida Miami, Florida, United States
  • ADVENTHEALTH (Data collection only) Orlando, Florida, United States
  • Mayo Clinic (Data Collection and Data Analysis) Rochester, Minnesota, United States
View all 18 locations
View Trial Details
Recruiting

Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer

NCT04918186

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • The University of Chicago Medical Center Chicago, Illinois, United States
  • BCCA - Kelowna Kelowna, British Columbia, Canada
  • BCCA - Vancouver Vancouver, British Columbia, Canada
  • Odette Cancer Centre Toronto, Ontario, Canada
View Trial Details
Recruiting

Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients

NCT04751435

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +38 more
Locations
  • Kings County Hopsital Center Brooklyn, New York, United States
  • Queens Cancer Center of Queens Hospital Jamaica, New York, United States
  • Memorial Sloan Kettering at Ralph Lauren Center (Limited Protocol Activities) New York, United States
  • Jamaica Hospital Medical Center (Data Collection Only) Richmond Hill, New York, United States
View Trial Details
Recruiting

AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer

NCT07218809

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +17 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Little Rock, Arkansas, United States
  • Research Site La Jolla, California, United States
  • Research Site Washington D.C., District of Columbia, United States
View all 299 locations
View Trial Details
Recruiting

A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

NCT07213609

Conditions
Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +22 more
Locations
  • GSK Investigational Site Aurora, Colorado, United States
  • GSK Investigational Site Detroit, Michigan, United States
  • GSK Investigational Site Canton, Ohio, United States
  • GSK Investigational Site Nashville, Tennessee, United States
View all 22 locations
View Trial Details
Recruiting

A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer

NCT06340568

Conditions
Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations
  • Yale University School of Medicine New Haven, Connecticut, United States
  • MedStar Washington Hospital Center Washington D.C., District of Columbia, United States
  • Broward Health Medical Center Fort Lauderdale, Florida, United States
  • OSF Saint Francis Medical Center Peoria, Illinois, United States
View all 171 locations
View Trial Details
Recruiting

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

NCT07114601

Conditions
Breast Diseases, Breast Neoplasms, Colonic Diseases, +37 more
Locations
  • City of Hope Duarte, California, United States
  • University of California, Los Angeles (UCLA) Santa Monica, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • Biogenix Molecular, LLC Miami, Florida, United States
View all 31 locations
View Trial Details

Related conditions